Combo Therapy May Prevent Cancer ' s Return After Liver Surgery
MONDAY, April 24, 2023 -- A two-drug combination therapy can enhance survival odds for people with early-stage liver cancer through targeted attacks on tumor cells, a new clinical trial shows.
The combo -- atezolizumab (Tecentriq) and bevacizumab...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Avastin | Cancer | Cancer & Oncology | Clinical Trials | General Medicine | Liver | Urology & Nephrology